ONCODERMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ONCODERMA
Largest movements
- Intangible fixed assets -€592
down €592 (-64.0%), from €925 to €333
- Receivables within one year -€276
down €276 (-51.5%), from €536 to €260
- Cash -€21
down €21 (-69.8%), from €31 to €9
mainly Net result for the year (-€9,156)
- Profit (loss) carried forward -€9,156
down €9,156 (-32.6%), from -€28,044 to -€37,200
- Trade debts +€3,573
up €3,573 (+41.2%), from €8,664 to €12,237
- Debts after one year +€3,100
up €3,100 (+19.0%), from €16,337 to €19,437
- Other debts +€1,594
new in 2024: €1,594
- Other operating charges +€2,578
new in 2024: €2,578
- Gross operating margin +€857
up €857 (+14.4%), from -€5,931 to -€5,074
- Financial charges +€730
up €730 (+401.7%), from €182 to €911
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,492 | €602 | -€889 | -59.6% |
| Fixed assets | 21/28 | €925 | €333 | -€592 | -64.0% |
| Intangible fixed assets | 21 | €925 | €333 | -€592 | -64.0% |
| Current assets | 29/58 | €567 | €269 | -€297 | -52.5% |
| Amounts receivable within one year | 40/41 | €536 | €260 | -€276 | -51.5% |
| Other amounts receivable | 41 | €536 | €260 | -€276 | -51.5% |
| Cash at bank and in hand | 54/58 | €31 | €9 | -€21 | -69.8% |
| Total equity and liabilities | 10/49 | €1,492 | €602 | -€889 | -59.6% |
| Equity | 10/15 | -€23,508 | -€32,664 | -€9,156 | -38.9% |
| Contributions | 10/11 | €4,536 | €4,536 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€28,044 | -€37,200 | -€9,156 | -32.6% |
| Amounts payable | 17/49 | €25,000 | €33,267 | +€8,267 | +33.1% |
| Amounts payable after more than one year | 17 | €16,337 | €19,437 | +€3,100 | +19.0% |
| Other amounts payable | 178/9 | €16,337 | €19,437 | +€3,100 | +19.0% |
| Amounts payable within one year | 42/48 | €8,664 | €13,830 | +€5,167 | +59.6% |
| Trade debts | 44 | €8,664 | €12,237 | +€3,573 | +41.2% |
| Suppliers | 440/4 | €8,664 | €12,237 | +€3,573 | +41.2% |
| Other amounts payable | 47/48 | - | €1,594 | +€1,594 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €592 | €592 | = | 0.0% |
| Other operating charges | 640/8 | - | €2,578 | +€2,578 | |
| Gross operating margin | 9900 | -€5,931 | -€5,074 | +€857 | +14.4% |
| Operating profit (loss) | 9901 | -€6,523 | -€8,244 | -€1,721 | -26.4% |
| Financial charges | 65/66B | €182 | €911 | +€730 | +401.7% |
| Recurring financial charges | 65 | €182 | €911 | +€730 | +401.7% |
| Profit (loss) for the period before taxes | 9903 | -€6,705 | -€9,156 | -€2,451 | -36.6% |
| Profit (loss) for the period | 9904 | -€6,705 | -€9,156 | -€2,451 | -36.6% |
| Profit (loss) for the period to be appropriated | 9905 | -€6,705 | -€9,156 | -€2,451 | -36.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.